Tubeless Insulin Pump Market Analysis Focusing on Top Key Players - Insulet Corporation, Johnson & Johnson, Medtrum Technologies, Roche Holding, Cellnovo Group, Spring Health Solution, Debiotech, CeQur, Valeritas & More

The prevalence of diabetes has been steadily increasing across the globe – indeed, according to reports published by the World Health Organization, compared to 108 million people who had diabetes in 1980, 422 million had been afflicted with the disorder in 2014. The tubeless insulin pump market has expanded not only due to rising demand from diabetic patients but also due to technological advances in the field of diabetes treatment. In 2015 1.6 million deaths had been a direct result of diabetes and WHO projects that by 2030 diabetes will become the seventh leading cause of death in the world. With lifestyle changes and irregularities urging the rising prevalence of obesity coupled with the growing global geriatric population, diabetes has become more common than ever before. With a major portion of the population suffering from diabetes reluctant to submit to the torture of daily insulin shots and finger pricks for blood glucose level testing, the tubeless insulin pump market is expected to gain greater prominence over the ensuing years.

MarketStudyReport.com Adds New Tubeless Insulin Pump Market 2017 – 2024 research report providing information and data By Component, By Distribution Channel, Industry Analysis, Regional Outlook, Technology Development, Competitive Landscape Market Share & Forecast spreading across 130 Pages with table and figures in it.

Tubeless Insulin Pump Market size is set to exceed USD 2 billion by 2024; according to a new research report. Rising number of diabetic and obese patients coupled with introduction of advanced pump will serve as high impact rendering factors for the tubeless insulin pump market growth.
Advent of new technologies in continuous glucose monitoring without the need for daily insulin injection doses will stimulate business growth over the forecast years. Growing adoption of minimally invasive insulin delivery methods should improve patient compliance.

Tubeless insulin pump remote should grow in parallel with the pods segment. Although the replacement rate of remotes is not as high as that of pods, their initial capital requirement is higher. Increasing sales of new tubeless insulin pump will fuel the significant growth of the remote market.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/568800/

Inadequate reimbursement coverage and high long-term cost associated with tubeless insulin pump will hamper its adoption in emerging economies. Compliance to insulin therapy may reduce owing to high maintenance therapy cost.

The pods/patches market should witness more than 20% CAGR over the coming years. Regular replacement of pods and high usage frequency will drive the escalated demand for these products.

Germany accounted for more than 20% of overall regional revenue share, owing to increasing number of diabetic patients and advanced healthcare system. Growing adoption of advanced technology will drive rapid industry grow over the forecast years.

Japan tubeless insulin pump market accounted for largest regional revenue share owing to its growing trend to adopt advanced technology. Rising per capita income of diabetic patients and high healthcare expenditure will promote tubeless insulin pump market growth.

China should witness lucrative growth in terms of revenue over the forecast period. Factors such as economic growth, large unaddressed diabetic population, rising disposable income, and improving healthcare facilities will propel business growth.

Brazil tubeless insulin pump market is projected to grow at 18% CAGR of over the forecast period. Availability of tubeless insulin pump in recent years will stimulate steady business expansion.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/568800/

Some of the companies operating in tubeless insulin pump market are Insulet Corporation, Johnson & Johnson, Medtrum Technologies, Roche Holding, Cellnovo Group, Spring Health Solution, Debiotech, CeQur, Valeritas, and Abbott Diabetes Care.

Table of Content:

Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. Tubeless Insulin Pump Industry Insight
Chapter 4. Tubeless Insulin Pump Market, By Component
Chapter 5. Tubeless Insulin Pump Market, By Distribution Channel
Chapter 6. Tubeless Insulin Pump Market, By Region
Chapter 7. Company Profiles

For More Details on this Report: https://www.marketstudyreport.com/reports/tubeless-insulin-pump-market

Outer Scope of this Report: Tubeless insulin pump market is expected to register massive growth as making diabetes manageable in a comfortable, effective and portable manner and better blood glucose level control is the best means of achieving improved patient compliance – tubeless insulin pumps have been very effective in this sphere. Novel devices like Omnipod are designed to calculate insulin dosage based on food database and schedules insulin delivery accordingly. Since lifestyles have evolved to become busier than ever, non-invasive insulin delivery methods as well as nasal, oral and buccal delivery modes are being explored and deployed adding future prospects for tubeless insulin pump market.

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Web site: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/

This release was published on openPR.